Logo image of CELH

CELSIUS HOLDINGS INC (CELH) Stock Fundamental Analysis

NASDAQ:CELH - Nasdaq - US15118V2079 - Common Stock

26.3301  -0.48 (-1.79%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CELH. CELH was compared to 31 industry peers in the Beverages industry. CELH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CELH shows excellent growth, but is valued quite expensive already. These ratings could make CELH a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CELH had positive earnings in the past year.
CELH had a positive operating cash flow in the past year.
Of the past 5 years CELH 4 years were profitable.
CELH had a positive operating cash flow in 4 of the past 5 years.
CELH Yearly Net Income VS EBIT VS OCF VS FCFCELH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

The Return On Assets of CELH (9.98%) is better than 75.00% of its industry peers.
The Return On Equity of CELH (13.63%) is comparable to the rest of the industry.
CELH has a better Return On Invested Capital (12.81%) than 64.29% of its industry peers.
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROIC 12.81%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A
CELH Yearly ROA, ROE, ROICCELH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

CELH has a Profit Margin of 12.41%. This is in the better half of the industry: CELH outperforms 67.86% of its industry peers.
In the last couple of years the Profit Margin of CELH has grown nicely.
CELH's Operating Margin of 17.01% is fine compared to the rest of the industry. CELH outperforms 60.71% of its industry peers.
In the last couple of years the Operating Margin of CELH has grown nicely.
The Gross Margin of CELH (49.59%) is comparable to the rest of the industry.
CELH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%
CELH Yearly Profit, Operating, Gross MarginsCELH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CELH is still creating some value.
The number of shares outstanding for CELH has been increased compared to 1 year ago.
The number of shares outstanding for CELH has been increased compared to 5 years ago.
The debt/assets ratio for CELH is higher compared to a year ago.
CELH Yearly Shares OutstandingCELH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CELH Yearly Total Debt VS Total AssetsCELH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 10.41 indicates that CELH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 10.41, CELH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
The Debt to FCF ratio of CELH is 0.00, which is an excellent value as it means it would take CELH, only 0.00 years of fcf income to pay off all of its debts.
CELH has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. CELH outperforms 89.29% of its industry peers.
CELH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, CELH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.41
ROIC/WACC1.38
WACC9.25%
CELH Yearly LT Debt VS Equity VS FCFCELH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

CELH has a Current Ratio of 4.71. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.71, CELH belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
CELH has a Quick Ratio of 4.03. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
CELH has a better Quick ratio (4.03) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 4.03
CELH Yearly Current Assets VS Current LiabilitesCELH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

CELH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
Measured over the past years, CELH shows a very strong growth in Earnings Per Share. The EPS has been growing by 91.57% on average per year.
CELH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.36%.
The Revenue has been growing by 90.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)50%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-30.93%

3.2 Future

The Earnings Per Share is expected to grow by 17.08% on average over the next years. This is quite good.
Based on estimates for the next years, CELH will show a quite strong growth in Revenue. The Revenue will grow by 12.32% on average per year.
EPS Next Y-8.84%
EPS Next 2Y10.6%
EPS Next 3Y15.09%
EPS Next 5Y17.08%
Revenue Next Year4.75%
Revenue Next 2Y10.09%
Revenue Next 3Y11.13%
Revenue Next 5Y12.32%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CELH Yearly Revenue VS EstimatesCELH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CELH Yearly EPS VS EstimatesCELH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.57, CELH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CELH indicates a slightly more expensive valuation: CELH is more expensive than 64.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, CELH is valued a bit more expensive.
CELH is valuated quite expensively with a Price/Forward Earnings ratio of 27.84.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CELH indicates a slightly more expensive valuation: CELH is more expensive than 60.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, CELH is valued at the same level.
Industry RankSector Rank
PE 36.57
Fwd PE 27.84
CELH Price Earnings VS Forward Price EarningsCELH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CELH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CELH is more expensive than 60.71% of the companies in the same industry.
CELH's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 36.47
EV/EBITDA 18.79
CELH Per share dataCELH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CELH has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CELH's earnings are expected to grow with 15.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.6%
EPS Next 3Y15.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CELH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CELSIUS HOLDINGS INC

NASDAQ:CELH (1/22/2025, 10:10:04 AM)

26.3301

-0.48 (-1.79%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners72.45%
Inst Owner Change1.34%
Ins Owners26.74%
Ins Owner Change-0.72%
Market Cap6.19B
Analysts80
Price Target41.17 (56.36%)
Short Float %20.01%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP16.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-42.81%
Min EPS beat(2)-100%
Max EPS beat(2)14.38%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-100%
Max EPS beat(4)36.12%
EPS beat(8)6
Avg EPS beat(8)-4.8%
EPS beat(12)9
Avg EPS beat(12)19.52%
EPS beat(16)11
Avg EPS beat(16)17.26%
Revenue beat(2)1
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-10.55%
Max Revenue beat(4)2.75%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)5.71%
Revenue beat(16)13
Avg Revenue beat(16)8.1%
PT rev (1m)-3.21%
PT rev (3m)-16.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.8%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.33%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-4.47%
Valuation
Industry RankSector Rank
PE 36.57
Fwd PE 27.84
P/S 4.51
P/FCF 36.47
P/OCF 32.16
P/B 4.96
P/tB 5.06
EV/EBITDA 18.79
EPS(TTM)0.72
EY2.73%
EPS(NY)0.95
Fwd EY3.59%
FCF(TTM)0.72
FCFY2.74%
OCF(TTM)0.82
OCFY3.11%
SpS5.83
BVpS5.31
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROCE 16.48%
ROIC 12.81%
ROICexc N/A
ROICexgc N/A
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
FCFM 12.38%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y36.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y62%
ROICexc growth 5YN/A
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 379.26%
Cap/Sales 1.66%
Interest Coverage 250
Cash Conversion 80.45%
Profit Quality 99.75%
Current Ratio 4.71
Quick Ratio 4.03
Altman-Z 10.41
F-Score7
WACC9.25%
ROIC/WACC1.38
Cap/Depr(3y)407.35%
Cap/Depr(5y)253.69%
Cap/Sales(3y)1.2%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-8.84%
EPS Next 2Y10.6%
EPS Next 3Y15.09%
EPS Next 5Y17.08%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-30.93%
Revenue Next Year4.75%
Revenue Next 2Y10.09%
Revenue Next 3Y11.13%
Revenue Next 5Y12.32%
EBIT growth 1Y27.71%
EBIT growth 3Y226.22%
EBIT growth 5YN/A
EBIT Next Year-8.9%
EBIT Next 3Y14.36%
EBIT Next 5Y14.89%
FCF growth 1Y38.83%
FCF growth 3Y253.59%
FCF growth 5YN/A
OCF growth 1Y52.16%
OCF growth 3Y246.31%
OCF growth 5YN/A